Koetsu Inoue

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Daisuke Douchi · 4 shared papers, 2017–2025 · strength 0.56
   • Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
   • Paper [A Case of an Elderly Patient Who Underwent Conversion Resection for Pancreatic Cancer with Positive Peritoneal Cytolog… PMID 36807179↗
   • Paper Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer. DOI 10.1016/j.pan.2022.11.010↗
2. Michiaki Unno · 4 shared papers, 2017–2025 · strength 0.56
   • Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
   • Paper [A Case of an Elderly Patient Who Underwent Conversion Resection for Pancreatic Cancer with Positive Peritoneal Cytolog… PMID 36807179↗
   • Paper Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer. DOI 10.1016/j.pan.2022.11.010↗
3. Masahiro Iseki · 3 shared papers, 2023–2025 · strength 0.50
   • Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
   • Paper [A Case of an Elderly Patient Who Underwent Conversion Resection for Pancreatic Cancer with Positive Peritoneal Cytolog… PMID 36807179↗
   • Paper Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer. DOI 10.1016/j.pan.2022.11.010↗
4. Masamichi Mizuma · 3 shared papers, 2023–2025 · strength 0.50
   • Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
   • Paper [A Case of an Elderly Patient Who Underwent Conversion Resection for Pancreatic Cancer with Positive Peritoneal Cytolog… PMID 36807179↗
   • Paper Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer. DOI 10.1016/j.pan.2022.11.010↗
5. Shuichi Aoki · 3 shared papers, 2023–2025 · strength 0.50
   • Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
   • Paper [A Case of an Elderly Patient Who Underwent Conversion Resection for Pancreatic Cancer with Positive Peritoneal Cytolog… PMID 36807179↗
   • Paper Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer. DOI 10.1016/j.pan.2022.11.010↗
6. Fuyuhiko Motoi · 3 shared papers, 2017–2025 · strength 0.40
   • Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
   • Paper Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer. DOI 10.1016/j.pan.2022.11.010↗
   • Paper MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction… DOI 10.1097/mpa.0000000000000778↗
7. Mitsuhiro Shimura · 2 shared papers, 2023–2025 · strength 0.35
   • Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
   • Paper Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer. DOI 10.1016/j.pan.2022.11.010↗
8. Kei Nakagawa · 2 shared papers, 2023 · strength 0.30
   • Paper [A Case of an Elderly Patient Who Underwent Conversion Resection for Pancreatic Cancer with Positive Peritoneal Cytolog… PMID 36807179↗
   • Paper Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer. DOI 10.1016/j.pan.2022.11.010↗
9. Takanori Morikawa · 2 shared papers, 2023 · strength 0.30
   • Paper [A Case of an Elderly Patient Who Underwent Conversion Resection for Pancreatic Cancer with Positive Peritoneal Cytolog… PMID 36807179↗
   • Paper Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer. DOI 10.1016/j.pan.2022.11.010↗
10. Shimpei Maeda · 1 shared paper, 2025 · strength 0.20
    • Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
11. Aya Noguchi · 1 shared paper, 2025 · strength 0.20
    • Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
12. Shingo Yoshimachi · 1 shared paper, 2025 · strength 0.20
    • Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
13. Naohiro Hirano · 1 shared paper, 2023 · strength 0.15
    • Paper [A Case of an Elderly Patient Who Underwent Conversion Resection for Pancreatic Cancer with Positive Peritoneal Cytolog… PMID 36807179↗
14. Kei Kawaguchi · 1 shared paper, 2017 · strength 0.06
    • Paper MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction… DOI 10.1097/mpa.0000000000000778↗
15. Shuhei Kawasaki · 1 shared paper, 2017 · strength 0.06
    • Paper MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction… DOI 10.1097/mpa.0000000000000778↗
16. Yu Katayose · 1 shared paper, 2017 · strength 0.06
    • Paper MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction… DOI 10.1097/mpa.0000000000000778↗
17. Shinichi Egawa · 1 shared paper, 2017 · strength 0.06
    • Paper MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction… DOI 10.1097/mpa.0000000000000778↗
18. Tetsuya Terasaki · 1 shared paper, 2017 · strength 0.06
    • Paper MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction… DOI 10.1097/mpa.0000000000000778↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.